Beta-2 agonist.
Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD
10
Inhaled beta 2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury
7
Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis
12
Clinical role of dual bronchodilation with an indacaterol–glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of life
10
Trend of cost and utilization of COPD medication in Korea
7
The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease
13
Functional imaging using computer methods to compare the effect of salbutamol and ipratropium bromide in patient-specific airway models of COPD
10
Do beta –2 Agonists reduce Admission rate in children with bronchiolitis?
20
Effect of sympathomimetics on gastrin secretion from antral G cells in culture
6
Validation of sensitive spectrophotometric method for determination of Salmeterol xinafoate and Fenoterol hydrobromide via o-Phenanthroline and iron complexation
6
Reactivation of latent HIV 1 in central memory CD4+T cells through TLR 1/2 stimulation
15
A qualitative evaluation of the implementation of guidelines and a support tool for asthma management in primary care
16
Effects of Dietary Beta-Adrenergic Agonist, Terbutaline, on Carcass Characteristics and Blood Attributes in Japanese Quails (Coturnix coturnix japonica)
9
Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts
11
Beta Adrenergic Receptors of Polymorphonuclear Particulates in Bronchial Asthma
10
Profile of mirabegron in the treatment of overactive bladder: place in therapy
5
Role of alpha adrenoceptors in opossum internal anal sphincter
7
Protective effects of a glucocorticoid on downregulation of pulmonary beta 2 adrenergic receptors in vivo
9
The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice
14
C Jun NH2 Terminal Kinase Contributes to Dexmedetomidine Induced Contraction in Isolated Rat Aortic Smooth Muscle
9